Your Article Summary
See Latest ArticlesUltrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age-related macular degeneration
Acta Ophthalmologica, 06/29/09
Bonnin P et al. - Intravitreal bevacizumab acutely improved VA and reduced central macular thickness in wet AMD. Ultrasound imaging revealed that BFVs decreased in all retrobulbar arteries, suggesting that after local diffusion, bevacizumab exerts a short-term regional effect. Bevacizumab might therefore induce hypoperfusion of the whole eye, which may correspond to a vascular side-effect.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09
Retinopathy of Prematurity
NeoReviews, 11/04/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09